Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Flavonoids in Ampelopsis grossedentata as covalent inhibitors of SARS-CoV-2 3CLpro: Inhibition potentials, covalent binding sites and inhibitory mechanisms
Yuan Xiong, Guanghao Zhu, Yani Zhang, et al.
International Journal of Biological Macromolecules (2021) Vol. 187, pp. 976-987
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

The SARS‐CoV‐2 main protease (Mpro): Structure, function, and emerging therapies for COVID‐19
Qing Hu, Yuan Xiong, Guanghao Zhu, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 144
The research progress of SARS-CoV-2 main protease inhibitors from 2020 to 2022
Xiaojing Pang, Wei Xu, Yang Liu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 257, pp. 115491-115491
Open Access | Times Cited: 57
Structure and function of SARS-CoV and SARS-CoV-2 main proteases and their inhibition: A comprehensive review
Xin Li, Yongcheng Song
European Journal of Medicinal Chemistry (2023) Vol. 260, pp. 115772-115772
Open Access | Times Cited: 51
Cys44 of SARS-CoV-2 3CLpro affects its catalytic activity
Ilaria Iacobucci, Irene Cipollone, Flora Cozzolino, et al.
International Journal of Biological Macromolecules (2025), pp. 139590-139590
Closed Access | Times Cited: 1
Promising Antiviral Activities of Natural Flavonoids against SARS-CoV-2 Targets: Systematic Review
Ridhima Kaul, Pradipta Paul, Sanjay Kumar, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11069-11069
Open Access | Times Cited: 76
The Therapeutic Potential of Natural Dietary Flavonoids against SARS-CoV-2 Infection
Zhonglei Wang, Liyan Yang
Nutrients (2023) Vol. 15, Iss. 15, pp. 3443-3443
Open Access | Times Cited: 25
Anti-Entry Activity of Natural Flavonoids against SARS-CoV-2 by Targeting Spike RBD
Jieru Meng, Jiazheng Liu, Lu Fu, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 160-160
Open Access | Times Cited: 17
Discovery and characterization of the covalent SARS-CoV-2 3CLpro inhibitors from Ginkgo biloba extract via integrating chemoproteomic and biochemical approaches
Yani Zhang, Guanghao Zhu, Wei Liu, et al.
Phytomedicine (2023) Vol. 114, pp. 154796-154796
Open Access | Times Cited: 15
Danshensu inhibits SARS-CoV-2 by targeting its main protease as a specific covalent inhibitor and discovery of bifunctional compounds eliciting antiviral and anti-inflammatory activity
Ruyu Wang, Xuwen Chen, Hongtao Li, et al.
International Journal of Biological Macromolecules (2023) Vol. 257, pp. 128623-128623
Closed Access | Times Cited: 15
Scutellarin activates IDH1 to exert antitumor effects in hepatocellular carcinoma progression
Zhao Cui, Caifeng Li, Wei Liu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 4
Open Access | Times Cited: 6
Identification of two flavonoids antiviral inhibitors targeting 3C-like protease of porcine epidemic diarrhea virus
Zhonghua Li, Liangyun Zhu, Lu Wang, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 5
Insights into SARS-CoV-2 structure: Approaches and action of SARS-CoV-2 main protease inhibitor
Ilma Shakeel, Aaliya Taiyab, Aanchal Rathi, et al.
Elsevier eBooks (2025), pp. 89-117
Closed Access
Ethyl caffeate as a novel targeted inhibitor of 3CLpro with antiviral activity against porcine epidemic diarrhea virus
Limin Jiang, Minghui Gu, Jiawei Xiao, et al.
Virology (2025) Vol. 604, pp. 110406-110406
Closed Access
Uncovering the naturally occurring covalent inhibitors of SARS-CoV-2 Mpro from the Chinese medicine sappanwood and deciphering their synergistic anti-Mpro effects
Qing Hu, Yiwen Zhang, Yani Zhang, et al.
Journal of Ethnopharmacology (2025), pp. 119397-119397
Closed Access
Uncovering the covalent inhibitors of SARS-CoV-2 Mpro in Tibetan edible herb Rhodiola crenulata and their synergistic anti-Mpro mechanism
Guanghao Zhu, Yani Zhang, Yuan Xiong, et al.
Journal of Pharmaceutical Analysis (2025), pp. 101224-101224
Open Access
Vine tea (Ampelopsis grossedentata) — a different kind of tea hidden deep in the mountains of China: A comprehensive review of the nutritional profile, functional effect, and diverse applications as a novel raw material in food practices
Yanqiu Zhang, Taotao Wang, Shanshan Wu, et al.
Trends in Food Science & Technology (2025) Vol. 159, pp. 104939-104939
Closed Access
AI-Driven Discovery of Highly Specific and Efficacious hCES2A Inhibitors for Ameliorating Irinotecan-Triggered Gut Toxicity
Zhipei Sang, Ya Zhang, Yufan Fan, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Discovery of 9,10-dihydrophenanthrene derivatives as SARS-CoV-2 3CLpro inhibitors for treating COVID-19
Jianwei Zhang, Yuan Xiong, Feng Wang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 228, pp. 114030-114030
Open Access | Times Cited: 32
Standards-Based UPLC-Q-Exactive Orbitrap MS Systematically Identifies 36 Bioactive Compounds in Ampelopsis grossedentata (Vine Tea)
Rongxin Cai, Xican Li, Chunhou Li, et al.
Separations (2022) Vol. 9, Iss. 11, pp. 329-329
Open Access | Times Cited: 24
Strategic developments in the drug delivery of natural product dihydromyricetin: applications, prospects, and challenges
Ruirui Zhang, Hao Zhang, Houyin Shi, et al.
Drug Delivery (2022) Vol. 29, Iss. 1, pp. 3052-3070
Open Access | Times Cited: 22
Plant‐derived compounds as potential leads for new drug development targeting COVID‐19
Lingxiu Liu, Maxim V. Kapralov, Mark Ashton
Phytotherapy Research (2024) Vol. 38, Iss. 3, pp. 1522-1554
Open Access | Times Cited: 3
Design and synthesis of APN and 3CLpro dual‐target inhibitors based on STSBPT with anticoronavirus activity
Youle Zheng, Feng Jin, Yanbin Song, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 3
Closed Access | Times Cited: 3
Natural Flavonoid Derivatives Have Pan-Coronavirus Antiviral Activity
Mattia Mori, Deborah Quaglio, Andrea Calcaterra, et al.
Microorganisms (2023) Vol. 11, Iss. 2, pp. 314-314
Open Access | Times Cited: 9
Ampelopsis grossedentata improves type 2 diabetes mellitus through modulating the gut microbiota and bile acid metabolism
Yuli Hu, Mei Li, Lei Ding, et al.
Journal of Functional Foods (2023) Vol. 107, pp. 105622-105622
Open Access | Times Cited: 9
Discovery of the covalent SARS‐CoV‐2 Mpro inhibitors from antiviral herbs via integrating target‐based high‐throughput screening and chemoproteomic approaches
Yani Zhang, Guanghao Zhu, Wei Liu, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 11
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top